Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000631144 | SCV000752142 | uncertain significance | Glycogen storage disease type III | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with cysteine at codon 1043 of the AGL protein (p.Gly1043Cys). The glycine residue is weakly conserved and there is a large physicochemical difference between glycine and cysteine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with AGL-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000631144 | SCV002094521 | uncertain significance | Glycogen storage disease type III | 2021-04-29 | no assertion criteria provided | clinical testing |